New obesity injection enters human testing
NCT ID NCT07291232
Summary
This is an early-stage study to test the safety and effects of an investigational drug called ABBV-295, given as an injection under the skin, in adults with obesity. The main goals are to check for side effects, see how the body processes the drug, and measure any changes in body weight. About 96 participants will receive either the active drug or a placebo (an inactive shot) to compare the results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 278624
RECRUITINGGrayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.